Three words get used as though they're one thing: saturated fat, cholesterol, LDL. They aren't. Saturated fat is a component of food. Cholesterol is a molecule your body makes and uses. LDL is a particle that carries cholesterol around your bloodstream. Most arguments about meat and heart health are two groups of people talking past each other because nobody defined the terms.
This article defines them. It also explains the piece neither camp usually covers: de novo lipogenesis — the process by which your liver builds saturated fat out of carbohydrate. That matters, because the saturated fat circulating in your blood doesn't all arrive from your plate.
What this article won't do is tell you what to eat, what your numbers should be, or that the dietary guidelines are wrong. If a recent blood test surprised you, the person to talk to is your doctor — the goal here is that you understand what they tell you.
The Difference Between Fat and Cholesterol — and Where LDL Fits
The short answer: fat and cholesterol are different substances that happen to travel together. Saturated fat is a type of fat found in food. Cholesterol is a waxy, ring-shaped molecule your body manufactures itself and uses to build cells and hormones. LDL is neither — it's the particle that carries cholesterol around your bloodstream. Three different things, routinely spoken of as one.
Here they are properly.
Saturated fat is a category of fatty acid — "saturated" describes chemical structure, a carbon chain with no double bonds. It isn't one substance. The most commonly eaten are palmitic acid (16 carbons), stearic acid (18), myristic acid (14) and lauric acid (12): meat and dairy supply most palmitic and stearic acid, while myristic and lauric acid come largely from dairy and tropical oils such as coconut. That isn't pedantry — as you'll see, these fatty acids behave differently from each other.
Cholesterol isn't a fat in the everyday sense at all. It's a waxy, ring-structured molecule your cells use to build their membranes and as raw material for bile acids, steroid hormones and vitamin D. You can't live without it, and your body doesn't rely on your diet to supply it: human cells produce roughly 700–900 mg a day themselves, while a typical diet supplies a few hundred milligrams (a mean of about 293 mg a day in the US) — of which, on average, only about half is absorbed.
LDL is neither of those things. Cholesterol doesn't dissolve in blood, so it travels inside protein-and-lipid packages called lipoproteins. LDL — low-density lipoprotein — is one of those carriers. When a blood panel reports "LDL cholesterol", it's reporting how much cholesterol is riding inside your LDL particles: cargo inside a carrier, three steps removed from the butter on your plate.
So "saturated fat raises your cholesterol" compresses a chain of separate steps — food component, absorption, hepatic handling, particle population, particle cholesterol content — into four words. The compression is where the arguing starts.
Why You're Told to Eat Less Saturated Fat — the Actual Mechanism
The mainstream advice is not vague, and it hasn't quietly gone away. The Dietary Guidelines for Americans, 2020–2025 lists it among its explicit limits: "Saturated fat—Less than 10 percent of calories per day starting at age 2."
The American Heart Association's 2026 dietary guidance statement, published in Circulation in March 2026, keeps saturated fat in the picture too. The AHA's own published summary of that statement lists among the features of a heart-healthy dietary pattern "choosing sources of unsaturated fats in place of sources of saturated fat", and notes that such patterns are "unlikely to exceed 10% of energy from saturated fat." The same summary draws a distinction worth reading carefully, because it is the mainstream position: "For most people, dietary cholesterol is no longer a primary target for CVD risk reduction." Current guidance treats saturated fat and dietary cholesterol differently.
Here is the mechanism, and it's a real one. From the Endotext clinical reference chapter on diet and lipids: "Dietary SFA have been shown to decrease hepatic LDL receptor activity, protein, and mRNA levels and this results in a decrease in the clearance of circulating LDL leading to increased LDL-C levels."
In plain language: your liver clears LDL particles from the bloodstream by grabbing them with LDL receptors on its cell surface. How many receptors it builds depends on how much free cholesterol sits inside the liver cell — high free cholesterol switches off a transcription factor called SREBP, and SREBP is what tells the cell to make more receptors. Saturated fatty acids appear to reduce the conversion of free cholesterol into stored cholesterol esters, leaving more free cholesterol behind, suppressing SREBP, meaning fewer receptors and slower clearance of LDL. Dietary cholesterol reaches the same step by a different route: absorbed cholesterol arrives at the liver in chylomicrons, raising hepatic cholesterol and down-regulating the same receptors.
Two pieces of nuance that live inside that position rather than against it. The effect appears roughly linear across a wide range of intakes, including below 10% of energy. And individual saturated fatty acids differ: in a meta-analysis of 60 controlled trials, lauric, myristic and palmitic acid raised LDL cholesterol, while stearic acid did not.
Nothing later in this article contradicts any of that.
Where the Blood Fat Actually Comes From — Your Liver Makes It Too
Here's the part that usually goes missing. The fatty acids circulating in your blood have more than one origin: some arrive from food, some are released from your own fat stores, and some are built from scratch inside your liver, by a process called de novo lipogenesis — literally, "new fat making".
De novo lipogenesis is the synthesis of fatty acids from acetyl-CoA, and in humans that acetyl-CoA comes most commonly from carbohydrate breakdown. Glucose feeds it; fructose feeds it particularly readily, because fructose metabolism bypasses a key insulin-regulated control point. The main fatty acid your liver produces this way is palmitic acid — a saturated fatty acid. Some is then elongated into stearic acid.
That's the point of this section: your liver manufactures saturated fat, and the raw material is carbohydrate. Saturated fat in your bloodstream is not a simple readout of saturated fat on your fork.
This is also where palmitoleic acid comes in. An enzyme called stearoyl-CoA desaturase 1 (SCD1) converts palmitic acid (16:0) into palmitoleic acid (16:1n-7), and because palmitoleic acid in humans originates mostly from this internal pathway rather than from food, researchers use it as a surrogate marker for de novo lipogenesis activity. A 2015 study in the American Journal of Clinical Nutrition found the palmitoleic acid content of VLDL-triglyceride tracked isotope-measured de novo lipogenesis and liver fat, and — unlike palmitic acid itself — did not track dietary intake. "Surrogate" is doing real work there: it's an indirect estimate, and measuring de novo lipogenesis properly requires isotope tracers.
A quieter point worth sitting with: most people can't say with any accuracy what they ate in the six weeks before a blood test. Dietary recall is unreliable enough that it's a named limitation in published nutrition research. If you're mid-way through a dietary change, the most useful thing you can do is keep an actual record rather than a remembered one — that's what Carnivore Lifestyles is for, so the conversation with your doctor starts from data instead of impressions.
What a Low-Carb Trial Found, and What It Did Not Find
In 2026 the American Journal of Clinical Nutrition published a secondary analysis by Rasmussen and colleagues of a Danish randomised controlled trial (NCT03068078). Seventy-one adults with type 2 diabetes were randomised 2:1 to a low-carbohydrate diet (maximum 20% of energy from carbohydrate) or a control diet following Danish national guidelines (50–60% carbohydrate, saturated fat under 10% of energy), for six months, with no calorie restriction.
What it found: the low-carbohydrate group's self-reported saturated fat intake rose 2.6-fold. Their circulating saturated fatty acids went down, not up — total saturated fatty acids in the serum phospholipid fraction fell relative to control at both three and six months (mean difference in change at six months −0.6 weight percent, 95% CI −0.9 to −0.2). Palmitoleic acid, the de novo lipogenesis marker, fell 23% relative to control at six months.
Before anyone over-reads that: these are compositional measurements — the proportion of each fatty acid within the total, as weight percent, not a concentration. Total circulating free fatty acid concentration did not differ between groups. "Less saturated fat in the blood" here means a smaller share of the mix, and the shift is modest: about 42.6% down to 41.9% of the phospholipid pool.
What it did not find matters at least as much. In the authors' own words: "No significant mean differences in change were observed for blood pressure, triglycerides, total cholesterol, LDL cholesterol, or HDL cholesterol after 6 mo."
That is a null result on LDL. It is not an LDL benefit and should not be repeated as one.
It is also heavily constrained by who was in the study. Entry required well-treated dyslipidaemia — participants were being managed toward an LDL cholesterol below 2.5 mmol/L and total cholesterol below 4.5 mmol/L. This was a pharmacologically managed group, and "no change in LDL" in people whose LDL is already under medical control tells you very little about what would happen in someone who isn't being treated.
The other limits, stated by the authors:
- It is a secondary analysis, and the secondary outcomes were not statistically powered.
- The trial was open-label and dietary intake self-reported — the authors name recall bias as a limitation.
- The low-carbohydrate group also lost more weight (a 3.9 kg mean difference), and change in circulating saturated fatty acids correlated with change in BMI and fat mass; weight loss can't be ruled out as a contributor.
- The population is adults with type 2 diabetes on glucose-lowering medication — not the general population, and not a carnivore or animal-based cohort.
- The trial did not measure cardiovascular events. The authors say so explicitly.
One earlier, smaller study points the same direction: a 2019 crossover study in JCI Insight found a low-carbohydrate diet containing 2.5 times more saturated fat decreased plasma total saturated fat and palmitoleate over four weeks. Two studies — one small and short, one six months in a specific patient group — is not a settled literature, and neither measured whether anything happened to anyone's heart.
The Danish authors' own conclusion is carefully hedged, and the hedge is the honest version: the diet altered fatty acid composition "in a manner consistent with a potentially favorable cardioprotective profile."
What This Does and Doesn't Change
It does not mean you should ignore your numbers. A lipid panel is information your doctor uses. This article gives you no basis for discounting one.
It is not dietary advice. If you have high cholesterol, this article does not tell you what to eat — deliberately.
What the distinction does add is narrower and more useful: dietary saturated fat intake and circulating saturated fatty acid composition are two different measurements, and in this trial they moved in opposite directions. Some of the saturated fat in your blood was assembled by your own liver out of carbohydrate. That is a fact about how the measurements relate. It is not permission.
What to Do If Your Results Surprised You
Take it to your doctor, and take context with you. A lipid panel read in isolation is a snapshot; the useful version includes what you'd been eating and for roughly how long, whether your weight had been changing, and whether anything about your medication had changed. If you're mid-way through a dietary transition, say so out loud in the appointment — the timing matters to how the result is read.
Ask your doctor to walk you through what each line on the panel actually measures. Most people have never had that explained, and the words on the printout are exactly the ones this article has been untangling. Don't try to interpret a single panel on your own, and don't act on one. Our guides on the keto to carnivore transition and the carnivore elimination diet cover what a structured change looks like — background for that conversation, not a substitute for it.
Track what you actually ate — not what you remember eating.
Carnivore Lifestyles logs your meals and symptoms side by side, so when you sit down with your doctor you're working from a record instead of a guess. Start your free trial → — 14 days free, no credit card required.
Frequently Asked Questions
What is the difference between fat and cholesterol?
Fat is an energy-storing nutrient made of fatty acids; cholesterol is a waxy structural molecule your body builds cells and hormones from. They are not the same substance, they do different jobs, and your body makes cholesterol whether or not you eat any. They get conflated because many foods contain both and because a blood test reports them in similar-looking units.
Is cholesterol the same thing as saturated fat?
No. Saturated fat is a category of fatty acid found in food. Cholesterol is a separate molecule your body manufactures — roughly 700–900 mg a day — and uses to build cell membranes, bile acids, steroid hormones and vitamin D. They occur together in many foods, which is part of why they get conflated, but they are chemically and functionally different substances.
What is de novo lipogenesis?
The process by which your liver builds fatty acids from scratch, using acetyl-CoA that most commonly comes from carbohydrate breakdown. The main product is palmitic acid, a saturated fatty acid — meaning some of the saturated fat circulating in your blood was made internally rather than eaten.
What is palmitoleic acid, and why do researchers measure it?
Palmitoleic acid (16:1n-7) is a monounsaturated fatty acid produced when the enzyme SCD1 modifies palmitic acid. Because it originates mostly from internal synthesis rather than food, it's used as an indirect marker of de novo lipogenesis activity. Direct measurement requires isotope tracer methods.
Does eating more saturated fat always mean more saturated fat in your blood?
The relationship is not one-to-one. In the Danish trial above, a group eating 2.6 times more saturated fat showed a smaller proportion of saturated fatty acids in their circulating phospholipids over six months — a finding about fatty acid composition in one trial, in adults with type 2 diabetes whose lipids were medically managed. Not a general rule, and the same trial found no change in LDL cholesterol.
Does this mean the advice to limit saturated fat is wrong?
No, and this article doesn't argue that. Current guidance from the Dietary Guidelines for Americans and the American Heart Association still recommends limiting saturated fat, and the mechanism behind it — reduced hepatic LDL receptor activity and slower LDL clearance — is well documented.
References
1. Hyde PN, Sapper TN, Crabtree CD, et al. 2019. Dietary carbohydrate restriction improves metabolic syndrome independent of weight loss. JCI Insight, 4(12):e128308. DOI: 10.1172/jci.insight.128308.
2. Lee JJ, Lambert JE, Hovhannisyan Y, et al. 2015. Palmitoleic acid is elevated in fatty liver disease and reflects hepatic lipogenesis. American Journal of Clinical Nutrition, 101(1):34–43. DOI: 10.3945/ajcn.114.092262. PMID: 25527748.
3. Rasmussen JLP, Gram-Kampmann EM, Stidsen JV, et al. 2026. Effect of a 6-month low-carbohydrate diet on the circulating fatty acid composition in patients with type 2 diabetes: a secondary analysis of an open-label randomized controlled trial. American Journal of Clinical Nutrition, 124:101400. DOI: 10.1016/j.ajcnut.2026.101400. Trial registration: NCT03068078.
4. Sanders FWB, Griffin JL. 2016. De novo lipogenesis in the liver in health and disease: more than just a shunting yard for glucose. Biological Reviews, 91(2):452–468. DOI: 10.1111/brv.12178. PMID: 25740151.
5. Shi Q, Chen J, Zou X, Tang X. 2022. Intracellular Cholesterol Synthesis and Transport. Frontiers in Cell and Developmental Biology, 10:819281. DOI: 10.3389/fcell.2022.819281. PMID: 35386193.
6. Feingold KR. The Effect of Diet on Cardiovascular Disease and Lipid and Lipoprotein Levels. In: Endotext [Internet]. MDText.com, Inc. NBK570127. PMID: 33945244.
7. Lichtenstein AH, Khera A, Anderson CAM, et al.; American Heart Association. 2026. 2026 Dietary Guidance to Improve Cardiovascular Health: A Scientific Statement From the American Heart Association. Circulation. DOI: 10.1161/CIR.0000000000001435. Quoted features and summary text from the AHA's published "Top Things to Know" summary of the statement.
8. Sacks FM, Lichtenstein AH, Wu JHY, et al.; American Heart Association. 2017. Dietary Fats and Cardiovascular Disease: A Presidential Advisory From the American Heart Association. Circulation. DOI: 10.1161/CIR.0000000000000510.
9. U.S. Department of Agriculture and U.S. Department of Health and Human Services. Dietary Guidelines for Americans, 2020–2025, 9th Edition. December 2020.
Medical disclaimer: This article is for educational purposes only and does not constitute medical advice. Always consult with a qualified healthcare professional before making significant dietary changes, particularly if you are managing a diagnosed medical condition, taking prescribed medication, or have a history of disordered eating. The carnivore or animal-based elimination approach involves significant dietary restriction — appropriate professional supervision is especially important for anyone with a history of nutritional deficiency, kidney disease, or cardiovascular conditions. Blood lipid results have multiple causes and multiple contributors, some of which require specific medical management; if you have high cholesterol, existing cardiovascular disease, or are taking lipid-lowering medication such as a statin, discuss any dietary change with your doctor first, and do not stop, reduce or alter that medication on the basis of anything you have read here. If you suspect a true food allergy (especially one causing severe or anaphylactic reactions), seek evaluation from a board-certified allergist. For pet dietary changes, always work alongside a qualified veterinarian.